Subscribe to RoboticOncology.com RSS Feed

Robotic Prostatectomy Yields Cleaner Surgical Margins

NEW YORK, NY--(Marketwired - Mar 20, 2014) -  A new prostate cancer study demonstrated that robotic prostate surgery produces fewer positive surgical margins and requires less use of additional cancer therapy within two years of the surgery.

In a UCLA-lead comparative review of robotic prostate surgery verses open surgery, the findings indicated that robotic surgery reduces the risk of positive surgical margins by 5 percent and also reduces the need for secondary prostate cancer treatment. David B. Samadi, MD, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital, believes these findings have widespread implications.

"We continue to see evidence of robotic surgery success being amplified in the hands of experienced surgeons," Dr. Samadi said. Using his own enhanced procedure, the Samadi Modified Advanced Robotic Technique (SMART), he has successfully performed 5,600 robotic radical prostatectomies. "Successful and thorough removal of cancerous tissue depends on a variety of factors: the dexterity of robotic tools, a bloodless surgical field, and most importantly, a highly skilled and experienced surgeon," he said.

After surgery, the removed prostate tissue is assessed on the volume of cancer cells in the margins. A positive surgical margin indicates that some prostate cancer may remain in the body, thereby increasing the chances of metastasis or recurrence. Surgical margin results are often used to determine whether secondary treatment, such as radiation or hormone therapy, is necessary.

In this study, positive surgical margins were present in 13.6 percent of the 5,556 robotic surgery patients and 18.3 percent of the 7,878 open surgery patients. "Clean surgical margins mean a lower chance of disease recurrence, and may subsequently mean less follow-up care and fewer healthcare expenses. Collectively, the short- and long-term benefits of robotic prostate surgery are tremendous," stated Dr. Samadi.

The study findings appear online in European Urology, http://www.europeanurology.com/article/S0302-2838%2814%2900134-1/abstract/comparative-effectiveness-of-robot-assisted-versus-open-radical-prostatectomy-cancer-control

Dr. Samadi is internationally recognized for robotic surgery excellence. He performs SMART robotic prostate removal surgery at The Lenox Hill Hospital Prostate Cancer Center in New York City.

Back to Press Releases


Bookmark Using:
Facebook Twitter LinkedIn Email Yahoo

Share on Facebook

Call to Make an Appointment With Dr. David Samadi:

1-212-365-5000

Click the contact link to learn how Dr. Samadi can help treat your prostate cancer and give you back your quality of life.

* The benefits of robotic surgery cannot be guaranteed as surgery is both patient and procedure specific. Previous surgical results do not guarantee future outcomes.




Testimonials
Stepan S. , Russia, Moscow

  Best in this area, a “Leonardo of our time,” an outstanding human being and a true expert in the field of urologic oncology and robotic surgery - Dr. David Samadi.

more..
A.B., New York

"Please know that your actions are saving lives and making the world a better place.  You are truly an inspiration to me, my family and many others."

more..
Moshe T., Israel

לפני זמן קצר, כחודשיים אחרי שעברתי כריתה רדיקלית של בלוטת הערמונית בשיטה הרובוטית, בביצוע ד" דיויד סמאדי, מביה"ח "מאונט סיני" בניו יורק, שאל אותי אחד מחברי הטובים: "היום, בראייה לאחור, האם היית מחליט לעשות אותו דבר? אותה פרוצדורה? אצל אותו רופא?" "בדיוק אותו דבר!" עניתי מיד וללא כל היסוס. לא הייתי צריך לחשוב אפילו שנייה.

more..
V.G. New York

If there is such a thing as Cancer Treatment Heaven, it is under the gifted care of Dr. Samadi, his medical team, administrative staff and cancer treatment unit at Lenox Hill Hospital.

more..